BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Seaside Therapeutics 

700 Technology Square
Suite 201
Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/10/2013 7:59:45 AM    More...
Seaside Therapeutics' Drug May Help Some Autism Cases 9/20/2012 8:18:12 AM    More...
Seaside Therapeutics Named a “Fierce 15” Biotech Company for 2012 9/19/2012 9:51:43 AM    More...
Roche (RHHBY), Seaside Therapeutics to Research Autism Treatments 6/19/2012 6:34:06 AM    More...
Seaside Therapeutics Announces Issuance of Key Patent for Lead Autism Candidate STX209 3/28/2012 7:15:59 AM    More...
Seaside Therapeutics Presents Data on Potential Pharmaceutical Treatment for Improving Social Impairment in Autism Spectrum Disorders at 42nd Autism Society National Conference 7/11/2011 10:02:40 AM    More...
Seaside Therapeutics Initiates Phase 2b Study of STX209 in Autism Spectrum Disorders 6/21/2011 8:41:08 AM    More...
Seaside Therapeutics Initiates Pivotal Phase 3 Study of STX209 in Fragile X Syndrome 6/2/2011 10:38:41 AM    More...
Seaside Therapeutics Publishes Review of Advances in the Treatment of Fragile X Syndrome in American Chemical Society Chemical Neuroscience 5/18/2011 9:50:18 AM    More...
Seaside Therapeutics Reports Positive Data from Phase 2 Study of STX209 in Autism Spectrum Disorders 9/9/2010 11:25:06 AM    More...
12

//-->